Galectin Therapeutics
GALT
$3.23
Share price
2.87%
Change (1 day)
93.41%
Change (1 year)
Categories
EPS for Galectin Therapeutics (GALT)
EPS in 2023 (TTM): -$0.66
According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.66. In 2022 the company made an earnings per share (EPS) of -$0.65 a decrease over its 2021 EPS that were of -$0.52.
EPS history for Galectin Therapeutics from 2002 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.66 | 1.54% |
| 2022 | -$0.65 | 25% |
| 2021 | -$0.52 | 30% |
| 2020 | -$0.40 | -6.98% |
| 2019 | -$0.43 | 13.16% |
| 2018 | -$0.38 | -22.45% |
| 2017 | -$0.49 | -35.53% |
| 2016 | -$0.76 | -13.64% |
| 2015 | -$0.88 | 11.39% |
| 2014 | -$0.79 | -39.69% |
| 2013 | -$1.31 | 81.94% |
| 2012 | -$0.72 | -32.08% |
| 2011 | -$1.06 | 7.07% |
| 2010 | -$0.99 | -17.5% |
| 2009 | -$1.20 | 150% |
| 2008 | -$0.48 | -68% |
| 2007 | -$1.50 | 127.27% |
| 2006 | -$0.66 | -52.17% |
| 2005 | -$1.38 | -20.69% |
| 2004 | -$1.74 | 52.63% |
| 2003 | -$1.14 | -13.64% |
| 2002 | -$1.32 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | -$12.82 | 1,842.42% | 🇺🇸 USA |
 MannKind Corp MNKD | -$0.19 | -71.21% | 🇺🇸 USA |